Search research articles
Contact Us
Filters
Showing results (1-10 of 142) with videos related to
Page
of 15
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 25, 2025
Infectious risk with JAKi: What about atopic dermatitis?
Lea Hoisnard, Emilie Sbidian
The British Journal of Dermatology
|
June 30, 2025
Hormonal therapy and psoriasis risk: a new concern for women's health?
Sivem Afach, Emilie Sbidian
The Journal of Investigative Dermatology
|
September 15, 2009
How to validate outcome instruments for pemphigus
Sylvie Bastuji-Garin, Emilie Sbidian
JAAD Case Reports
|
March 10, 2021
Response to "New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019"
Florence Assan, Emilie Sbidian, Hervé Bachelez
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 31, 2021
Reply
Emilie Sbidian, Laëtitia Penso, Antoine Meyer
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2026
Comparative effectiveness of first-line anti-PD-1 versus cetuximab in advanced cutaneous squamous cell carcinoma: A nationwide population-based study using the French national health data system
Quentin Samaran, Thomas Bettuzzi, Emilie Sbidian
The Journal of Investigative Dermatology
|
March 30, 2023
First-Line Persistence of Biologics in Psoriasis from a Cohort Based on French Medico-Administrative Data
Clarisse Marcombes, Laetitia Penso, Emilie Sbidian
Rheumatology (Oxford, England)
|
December 3, 2025
Development and validation of a predictive model for the risk of serious infection in patients with rheumatoid arthritis initiating a biologic or targeted synthetic DMARD: a nationwide cohort study
Mounya Abboud, Mahmoud Zureik, Emilie Sbidian
Rheumatology (Oxford, England)
|
March 25, 2022
Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study: Reply
Laura Pina Vegas, Pascal Claudepierre, Emilie Sbidian
The Journal of Investigative Dermatology
|
December 23, 2022
Placebo Response in Moderate-to-Severe Psoriasis: Prevalence Meta-Analysis of Randomized Controlled Trials
Sivem Afach, Laurence Le Cleach, Emilie Sbidian
Page
of 15
Search research articles
Search
Showing results (1-10 of 142) with videos related to
Sort By:
Page
of 15
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 25, 2025
Infectious risk with JAKi: What about atopic dermatitis?
Lea Hoisnard, Emilie Sbidian
The British Journal of Dermatology
|
June 30, 2025
Hormonal therapy and psoriasis risk: a new concern for women's health?
Sivem Afach, Emilie Sbidian
The Journal of Investigative Dermatology
|
September 15, 2009
How to validate outcome instruments for pemphigus
Sylvie Bastuji-Garin, Emilie Sbidian
JAAD Case Reports
|
March 10, 2021
Response to "New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019"
Florence Assan, Emilie Sbidian, Hervé Bachelez
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 31, 2021
Reply
Emilie Sbidian, Laëtitia Penso, Antoine Meyer
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2026
Comparative effectiveness of first-line anti-PD-1 versus cetuximab in advanced cutaneous squamous cell carcinoma: A nationwide population-based study using the French national health data system
Quentin Samaran, Thomas Bettuzzi, Emilie Sbidian
The Journal of Investigative Dermatology
|
March 30, 2023
First-Line Persistence of Biologics in Psoriasis from a Cohort Based on French Medico-Administrative Data
Clarisse Marcombes, Laetitia Penso, Emilie Sbidian
Rheumatology (Oxford, England)
|
December 3, 2025
Development and validation of a predictive model for the risk of serious infection in patients with rheumatoid arthritis initiating a biologic or targeted synthetic DMARD: a nationwide cohort study
Mounya Abboud, Mahmoud Zureik, Emilie Sbidian
Rheumatology (Oxford, England)
|
March 25, 2022
Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study: Reply
Laura Pina Vegas, Pascal Claudepierre, Emilie Sbidian
The Journal of Investigative Dermatology
|
December 23, 2022
Placebo Response in Moderate-to-Severe Psoriasis: Prevalence Meta-Analysis of Randomized Controlled Trials
Sivem Afach, Laurence Le Cleach, Emilie Sbidian
Page
of 15